appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Astrazeneca Pharma India Ltd
ASTRAZEN
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.
Brands
Brands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Increased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has increased by 1.22%
Recent NewsAll news
Union Budget 2024: AstraZeneca set to gain from customs duty exemption on key cancer drugs in full Budget
1 month ago•Business Today
HDFC Bank Ltd leads losers in ‘A’ group
1 month ago•Business Standard
Volumes soar at Astrazeneca Pharma India Ltd counter
1 month ago•Business Standard
Recent EventsAll events
Shareholders meeting
AstraZeneca Pharma India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 08, 2024. Further, the company has informed the Exchange regarding voting results. | Download
AstraZeneca Pharma India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 08, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Shareholders meeting
AstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 08, 2024 along with a copy of minutes. | Download
AstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 08, 2024 along with a copy of minutes. | Download
Cash Dividend
Final • Div/Share: ₹ 24
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant